View in EDS

NHS-IL12 and bintrafusp alfa combination therapy enhances antitumor activity in preclinical cancer models.

Saved in:
Bibliographic Details
Title: NHS-IL12 and bintrafusp alfa combination therapy enhances antitumor activity in preclinical cancer models.
Authors: Xu C; EMD Serono Research and Development Institute, Inc, 45 Middlesex Turnpike, Billerica, MA 01821, USA. Electronic address: chunxiao.xu@emdserono.com., Marelli B; EMD Serono Research and Development Institute, Inc, 45 Middlesex Turnpike, Billerica, MA 01821, USA., Qi J; EMD Serono Research and Development Institute, Inc, 45 Middlesex Turnpike, Billerica, MA 01821, USA., Qin G; EMD Serono Research and Development Institute, Inc, 45 Middlesex Turnpike, Billerica, MA 01821, USA., Yu H; EMD Serono Research and Development Institute, Inc, 45 Middlesex Turnpike, Billerica, MA 01821, USA., Wang H; EMD Serono Research and Development Institute, Inc, 45 Middlesex Turnpike, Billerica, MA 01821, USA., Jenkins MH; EMD Serono Research and Development Institute, Inc, 45 Middlesex Turnpike, Billerica, MA 01821, USA., Lo KM; EMD Serono Research and Development Institute, Inc, 45 Middlesex Turnpike, Billerica, MA 01821, USA., Lan Y; EMD Serono Research and Development Institute, Inc, 45 Middlesex Turnpike, Billerica, MA 01821, USA. Electronic address: yan.lan@emdserono.com.
Source: Translational oncology [Transl Oncol] 2022 Feb; Vol. 16, pp. 101322. Date of Electronic Publication: 2021 Dec 23.
Publication Type: Journal Article
Journal Info: Publisher: Neoplasia Press Country of Publication: United States NLM ID: 101472619 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1936-5233 (Print) Linking ISSN: 19365233 NLM ISO Abbreviation: Transl Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1936-5233
DOI:10.1016/j.tranon.2021.101322